資本剰余金、損害賠償引当金、一般管理費及び当期製造費用に含まれる研究開発費他2件
- 【期間】
| 年度 | 資本剰余金 | 損害賠償引当金 | 一般管理費及び当期製造費用に含まれる研究開発費 | 関係会社債権放棄損 | 役員株式交付引当金 |
|---|
| 2007/03 | 81.2億 | | - | | - | | - | | - | |
| 2008/03 | 81.2億 | -0% | - | | - | | - | | - | |
| 2009/03 | 81.2億 | ±0% | - | | - | | - | | - | |
| 2010/03 | 81.2億 | ±0% | - | | - | | - | | - | |
| 2011/03 | 81.2億 | ±0% | - | | - | | - | | - | |
| 2012/03 | 81.2億 | ±0% | - | | - | | - | | - | |
| 2013/03 | 81.2億 | ±0% | - | | 51.2億 | | - | | - | |
| 2014/03 | 81.2億 | ±0% | - | | 54.2億 | +5.9% | - | | - | |
| 2015/03 | 81.2億 | ±0% | - | | 57.8億 | +6.7% | - | | - | |
| 2016/03 | 81.2億 | ±0% | - | | 56.1億 | -2.9% | - | | - | |
| 2017/03 | 81.2億 | ±0% | - | | 55億 | -2.1% | - | | - | |
| 2018/03 | 81.1億 | -0.1% | - | | 58億 | +5.5% | - | | - | |
| 2019/03 | 81.1億 | ±0% | 8百万 | | 58.1億 | +0.1% | - | | - | |
| 2020/03 | 81.1億 | ±0% | - | | 58.7億 | +1% | - | | - | |
| 2021/03 | 81.1億 | ±0% | - | | 57.4億 | -2.1% | - | | - | |
| 2022/03 | 81.1億 | ±0% | - | | 54.5億 | -5.2% | - | | - | |
| 2023/03 | 81.1億 | ±0% | - | | 56.4億 | +3.5% | 37.9億 | | - | |
| 2024/03 | 81.1億 | ±0% | - | | - | | - | | 32百万 | |
